Vietnam Cell and Gene Therapy Market Size, Share, Trends and Forecast 2025-2033

Market Overview

The Vietnam cell and gene therapy market size reached USD 86.17 Million in 2024 and is projected to reach USD 294.24 Million by 2033, growing at a CAGR of 14.62% during 2025-2033. Market growth is propelled by increasing healthcare investment, advancing genetic technology, and innovations in precision medicine. The expanding middle-class population and demand for advanced treatments further support market share growth. 

Study Assumption Years

• Base Year: 2024
• Historical Year/Period: 2019-2024
• Forecast Year/Period: 2025-2033

Vietnam Cell and Gene Therapy Market Key Takeaways

• Current Market Size: USD 86.17 Million (2024)
• CAGR: 14.62% (2025-2033)
• Forecast Period: 2025-2033
• Rising healthcare investment and infrastructure development is a major market driver in Vietnam.
• The Vietnamese genomics and genetic technology sector is rapidly expanding, positioning the country as a hub for genetic innovation.
• Precision medicine adoption is increasing, enabling targeted therapeutic approaches and advancing cell and gene therapy applications.
• Local firms like Gene Solutions dominate genetic testing with over 80% market share in reproductive health tests.
• Government initiatives include large-scale hospital upgrades through national projects.

Sample Request Link: https://www.imarcgroup.com/vietnam-cell-gene-therapy-market/requestsample

Market Growth Factors

Rising Healthcare Investment and Infrastructure Development

Vietnam's healthcare sector growth is significantly driven by substantial government and private investments in medical infrastructure. This financial commitment aims to upgrade medical facilities and expand advanced treatment accessibility. The aging population and reduced birth rate are increasing demand for specialty healthcare services such as cell and gene therapy. Public and private hospitals are modernizing and establishing new departments to address complex diseases, supported by large-scale national-level projects funded by the central government to upgrade hospitals across provinces.

Growing Genetic Technology Advancement

The Vietnamese genomics and genetic technology sector is experiencing remarkable growth, establishing Vietnam as an emerging hub for genetic innovation in Southeast Asia. Increased adoption of genetic testing, personalized medicine, and advanced molecular diagnostics supports market growth. Awareness of genetically-based treatments and diagnostics is rising among healthcare providers and patients. Gene Solutions leads the market with over 80% share in reproductive health tests, developing advanced liquid biopsy and cancer detection technologies. International collaborations promote knowledge transfer and technology adoption, fostering market development.

Enhanced Disease Treatment Innovation Through Precision Medicine

Vietnam's healthcare is shifting towards precision medicine and targeted therapies, creating significant opportunities for cell and gene therapy. Genetically-based treatments are increasingly recognized for addressing rare and complex diseases. Healthcare institutions are adopting personalized treatment protocols leveraging genetic data to optimize outcomes. Research capabilities and clinical expertise support sophisticated disease treatment approaches, focusing on cancers prevalent in Vietnam. Integration of AI and machine learning enhances diagnostic and therapeutic precision, fueling growth in personalized medicine and demand for advanced therapies.

Market Segmentation

Therapy Type Insights:

• Cell Therapy
• Stem Cell
• Pluripotent Stem Cell
• Cancer Stem Cell
• Adult Stem Cell
• Non-Stem Cell
• T-Cell
• Natural Killer Cell
• Others
• Gene Therapy

The report analyzes cell therapy, subdivided into stem cell types and non-stem cell types, and gene therapy.

Indication Insights:

• Cardiovascular Disease
• Oncology Disorder
• Genetic Disorder
• Infectious Disease
• Neurological Disorder
• Others

The segmentation covers therapy indications including several disease categories.

Delivery Mode Insights:

• In-Vivo
• Ex-Vivo

The market is segmented by delivery modes of therapy.

End User Insights:

• Hospitals
• Cancer Care Centers
• Pharmaceuticals and Biotechnology Companies
• Others

The report details market segmentation by user types receiving therapies.

Regional Insights:

• Northern Vietnam
• Central Vietnam
• Southern Vietnam

Comprehensive analysis of major regional markets is provided.

Regional Insights

Northern Vietnam, Central Vietnam, and Southern Vietnam are key regional markets for cell and gene therapy. The report provides a detailed analysis but does not specify dominance or exact statistical shares by region. Further specifics on regional market shares or CAGR are not provided in the source.

Northern, Central, and Southern Vietnam constitute the main geographic coverage of this market.

Competitive Landscape

The competitive landscape of the industry has also been examined along with the profiles of the key players.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302

United States: +1-201971-6302